Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARTAN: Atazanavir and Raltegravir in Treatment-Naive HIV
NCT00768989Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial of atazanavir and raltegravir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Nov 2008; status: terminated.
02
Drugs
atazanavirraltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00768989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00768989.